CN1634383A - Chinese violet containing capsule and its preparing process - Google Patents
Chinese violet containing capsule and its preparing process Download PDFInfo
- Publication number
- CN1634383A CN1634383A CN 200410081346 CN200410081346A CN1634383A CN 1634383 A CN1634383 A CN 1634383A CN 200410081346 CN200410081346 CN 200410081346 CN 200410081346 A CN200410081346 A CN 200410081346A CN 1634383 A CN1634383 A CN 1634383A
- Authority
- CN
- China
- Prior art keywords
- herba
- grams
- containing capsule
- lobeliae chinensis
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 28
- 240000006688 Telosma cordata Species 0.000 title claims description 20
- 235000017352 Telosma cordata Nutrition 0.000 title claims description 20
- 238000000034 method Methods 0.000 title claims description 7
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 26
- 239000010231 banlangen Substances 0.000 claims abstract description 18
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims abstract description 13
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 13
- 238000002360 preparation method Methods 0.000 claims description 19
- 239000003814 drug Substances 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 13
- 239000012141 concentrate Substances 0.000 claims description 12
- 239000006071 cream Substances 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 12
- 238000005303 weighing Methods 0.000 claims description 12
- QNHQEUFMIKRNTB-UHFFFAOYSA-N aesculetin Natural products C1CC(=O)OC2=C1C=C(O)C(O)=C2 QNHQEUFMIKRNTB-UHFFFAOYSA-N 0.000 claims description 7
- ILEDWLMCKZNDJK-UHFFFAOYSA-N esculetin Chemical compound C1=CC(=O)OC2=C1C=C(O)C(O)=C2 ILEDWLMCKZNDJK-UHFFFAOYSA-N 0.000 claims description 7
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 238000004809 thin layer chromatography Methods 0.000 claims description 7
- 238000011049 filling Methods 0.000 claims description 6
- 238000005469 granulation Methods 0.000 claims description 6
- 230000003179 granulation Effects 0.000 claims description 6
- 239000012535 impurity Substances 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 238000012856 packing Methods 0.000 claims description 6
- 238000012545 processing Methods 0.000 claims description 6
- 238000012216 screening Methods 0.000 claims description 6
- 239000004677 Nylon Substances 0.000 claims description 4
- 229920001778 nylon Polymers 0.000 claims description 4
- 238000001291 vacuum drying Methods 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 239000004744 fabric Substances 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 241000288784 Barleria cristata Species 0.000 abstract 1
- 241000208672 Lobelia Species 0.000 abstract 1
- 231100000614 poison Toxicity 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 206010017553 Furuncle Diseases 0.000 description 3
- 210000003026 hypopharynx Anatomy 0.000 description 3
- 238000001694 spray drying Methods 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010010741 Conjunctivitis Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- 241000256844 Apis mellifera Species 0.000 description 1
- 241000040710 Chela Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000239226 Scorpiones Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The disclosed capsule comprises Philippine violet herb, dandehon herb, radix isatidis, radical lobelia, talcum powder, and magnesium stearate.
Description
Technical field:
The present invention relates to a kind of heat-clearing and toxic substances removing, oral Chinese patent medicine preparation of dampness removing and preparation method thereof particularly, the present invention relates to that a kind of absorption is fast, curative effect is high, take and carry Chinese violet containing capsule and preparation method thereof more easily
Background technology:
Two fourths are to be used for furuncle carbuncle poison, affection due to external wind and heat, and laryngopharynx swelling and pain, the oral Chinese patent medicine preparation of wind heat acute catarrhal conjunctivitis, prescription comprise typical antipyretic and antidotal type Chinese medicinal ingredients.Clinical efficacy is not seen the clinical report of toxic side effect certainly.
At present, the oral Pharmaceutical dosage forms of two fourths only has two fourth electuaries a kind of, and has been put in the national drug standards, and its composition and prescription be through for many years clinical use, to treatment furuncle carbuncle poison, and affection due to external wind and heat, laryngopharynx swelling and pain, the wind heat acute catarrhal conjunctivitis has significant effect.But, because Chinese patent medicine granule does not thoroughly change the thick black situation of Chinese patent medicine, and also need add a large amount of sucrose or other adjuvants etc. for flavoring, therefore use and carry equal inconvenience, and be not suitable for diabetic to take because of it contains a large amount of sugar parts.Simultaneously, existing single traditional peroral dosage form also is unfavorable for the market competition and The development in society and economy, and for the sure Chinese prescription of curative effect that promotes traditional classical develops to modernization of Chinese medicine direction, we have developed the capsule of two fourths.
Summary of the invention:
The present invention is intended to overcome above-mentioned defective, and a kind of Chinese violet containing capsule of taking and carrying more convenient, easy preservation and preparation method thereof is provided.
For achieving the above object, the technical solution used in the present invention is as follows:
Chinese violet containing capsule is characterized in that becoming 1000 by the preparation of raw material of following weight parts:
Herba Violae 100～2000 gram Herba Taraxacis 100～2000 grams
Radix Isatidis 100～2000 gram Herba Lobeliae Chinensis 100～2000 grams
Pulvis Talci 14 gram magnesium stearate 4.2 grams
Operations such as the preparation method of described Chinese violet containing capsule comprises that raw material screening, weighing mix, decoct, filter, concentrate, dry, granulation and filling, check, concrete processing step is as follows:
A, Herba Violae, Herba Taraxaci, Radix Isatidis, Herba Lobeliae Chinensis four Chinese medicine material are removed impurity such as silt, reject dis-medicinal part after, again medicinal part is cut into long 1～1.5 centimetre section;
B, take by weighing the above-mentioned four flavor Chinese medicines of recipe quantity, add the purified water of 3～20 times of medical material amounts behind the mixing, decoct 2～3 times, decocted 1～3 hour at every turn;
C, the decocting liquid after will at every turn decocting remerges after filtering with 100 order silks or nylon cloth respectively;
D, the decocting liquid that adopts reduced vacuum to concentrate after mode will merge are condensed into the clear paste that relative density is 1.0～1.40 (50～55 ℃), adopt thin layer chromatography that wherein contained Herba Violae, Herba Taraxaci, Herba Lobeliae Chinensis are differentiated simultaneously;
E, be 100～150 ℃ in inlet temperature, leaving air temp is under 45～75 ℃ the condition, above-mentioned clear paste is sprayed or vacuum drying makes dried cream powder;
F, add the Pulvis Talci and the magnesium stearate of recipe quantity in above-mentioned dried cream powder, mixing is crossed 10～60 mesh sieves, and No. 0 capsule of packing into gets product, and adopts high performance liquid chromatography that the content of aesculetin in the finished product is detected simultaneously.
The best relative density of described clear paste is 1.08 (50～55 ℃).
The specification of described Chinese violet containing capsule finished product is: adorn 0.38 gram for every.
The content of described Chinese violet containing capsule finished product is a brown granular, feeble QI, bitter in the mouth; Its usage and dosage is: oral, one time 5,3 times on the one.
According to " Chinese herbal medicine commonly used " new purposes handbook record, raw material of the present invention has following performance:
Herba Violae: heat-clearing and toxic substances removing.Be usually used in: 1) pathopyretic ulcer card; 2) venom; Also can be used for the liver-heat conjunctival congestion and swelling pain in addition.
Herba Taraxaci: heat-clearing and toxic substances removing, dampness removing.Be usually used in: 1) cards such as mediocre swollen skin infection of pyretic toxicity and abscess of internal organ; 2) wet jaundice of heat and the puckery pain of dribbling urination; Also can be used for the order thorn in addition and swell and ache laryngopharynx swelling and pain.
Radix Isatidis: heat-clearing and toxic substances removing, removing heat from blood, sore-throat relieving.Be usually used in: 1) affection due to external wind and heat and epidemic febrile disease from the beginning of card such as heating, headache; 2) major part pestilent toxicity, cards such as women's head-ornaments redness, discomfort in the throat.
Herba Lobeliae Chinensis: heat-clearing and toxic substances removing, inducing diuresis to remove edema.Be usually used in: 1) venom, honeybee scorpion thorn chela, and furuncle is from the beginning of card such as swelling and ache; 2) extensive abdominal edema, face foot edema.
The invention has the advantages that:
1, only needs a spot of lubricant of adding promptly plastic behind the extract dry, need not add correctives and filler, carry and preserve more convenient;
2, five Chinese violet containing capsules promptly are equivalent to 20 grams, two fourth electuaries, and more convenient patient takes;
3, do not add sucrose, more help taking of diabetes patient;
4, quality standard has obtained comprehensive raising, and the thin layer chromatography that has increased Herba Violae, Herba Taraxaci, Herba Lobeliae Chinensis is differentiated; Set up aesculetin HPLC method algoscopy in the finished product, thereby the quantitative quality index that has more effectively realized finished product detects, this quality standard has more science, objective, reasonable and feasibility.
The specific embodiment:
Embodiment 1:
Chinese violet containing capsule is characterized in that becoming 1000 by the preparation of raw material of following recipe quantity: Herba Violae 1000 grams, Herba Taraxaci 1000 grams, Radix Isatidis 1000 grams, Herba Lobeliae Chinensis 1000 grams, Pulvis Talci 14 grams, magnesium stearate 4.2 grams.
The preparation method of Chinese violet containing capsule comprises that raw material screening, weighing mix, decoct, filter, concentrate, dry, granulation and filling, inspection process, and concrete processing step is as follows:
Herba Violae, Herba Taraxaci, Radix Isatidis, Herba Lobeliae Chinensis four Chinese medicine material are removed impurity such as silt, behind the rejecting dis-medicinal part, be cut into long 1～1.5 centimetre section again; Take by weighing Herba Violae, Herba Taraxaci, Radix Isatidis and the Herba Lobeliae Chinensis of above-mentioned recipe quantity, the decocting that adds 8 times of amounts behind the mixing boils 2 times, decocts 1.5 hours at every turn, and the decocting liquid after will at every turn decocting simultaneously filters the back with 100 order nylon cloths and merges; The decocting liquid that adopts reduced vacuum to concentrate after mode will merge is condensed into the clear paste that relative density is 1.08 (50～55 ℃), adopts thin layer chromatography that wherein contained Herba Violae, Herba Taraxaci, Herba Lobeliae Chinensis are differentiated simultaneously; In inlet temperature is 150 ℃, and leaving air temp is under 75 ℃ the condition, above-mentioned clear paste to be carried out spray drying make dried cream powder; The Pulvis Talci and the magnesium stearate that in dried cream powder, add recipe quantity then, mixing is crossed 40 mesh sieves, and No. 0 capsule of packing into gets product, and adopts high performance liquid chromatography that the content of aesculetin in the finished product is detected simultaneously.
Embodiment 2:
Chinese violet containing capsule is characterized in that becoming 1000 by the preparation of raw material of following recipe quantity: Herba Violae 2000 grams, Herba Taraxaci 2000 grams, Radix Isatidis 2000 grams, Herba Lobeliae Chinensis 2000 grams, Pulvis Talci 28 grams, magnesium stearate 8.4 grams.
The preparation method of Chinese violet containing capsule comprises that raw material screening, weighing mix, decoct, filter, concentrate, dry, granulation and filling, inspection process, and concrete processing step is as follows:
Herba Violae, Herba Taraxaci, Radix Isatidis, Herba Lobeliae Chinensis four Chinese medicine material are removed impurity such as silt, behind the rejecting dis-medicinal part, be cut into long 1～1.5 centimetre section again; Take by weighing Herba Violae, Herba Taraxaci, Radix Isatidis and the Herba Lobeliae Chinensis of above-mentioned recipe quantity, the decocting that adds 6 times of amounts behind the mixing boils 3 times, decocts 1.5 hours at every turn, and the decocting liquid after will at every turn decocting simultaneously filters the back with 100 order silks and merges; The decocting liquid that adopts reduced vacuum to concentrate after mode will merge is condensed into the clear paste that relative density is 1.08 (50～55 ℃), adopts thin layer chromatography that wherein contained Herba Violae, Herba Taraxaci, Herba Lobeliae Chinensis are differentiated simultaneously; In inlet temperature is 100 ℃, and leaving air temp is under 50 ℃ the condition, above-mentioned clear paste to be carried out vacuum drying make dried cream powder; Be to add in the cream powder Pulvis Talci and the magnesium stearate of recipe quantity then, mixing is crossed 20 mesh sieves, and No. 0 capsule of packing into gets product, and adopts high performance liquid chromatography that the content of aesculetin in the finished product is detected simultaneously.
Embodiment 3:
Chinese violet containing capsule is characterized in that becoming 1000 by the preparation of raw material of following recipe quantity: Herba Violae 3000 grams, Herba Taraxaci 3000 grams, Radix Isatidis 3000 grams, Herba Lobeliae Chinensis 3000 grams, Pulvis Talci 42 grams, magnesium stearate 12.6 grams.
The preparation method of Chinese violet containing capsule comprises that raw material screening, weighing mix, decoct, filter, concentrate, dry, granulation and filling, inspection process, and concrete processing step is as follows:
Herba Violae, Herba Taraxaci, Radix Isatidis, Herba Lobeliae Chinensis four Chinese medicine material are removed impurity such as silt, behind the rejecting dis-medicinal part, be cut into long 1～1.5 centimetre section again; Take by weighing Herba Violae, Herba Taraxaci, Radix Isatidis and the Herba Lobeliae Chinensis of above-mentioned recipe quantity, the decocting that adds 10 times of amounts behind the mixing boils 2 times, decocts 1.5 hours at every turn, and the decocting liquid after will at every turn decocting simultaneously filters the back with 100 order silks and merges; The decocting liquid that adopts reduced vacuum to concentrate after mode will merge is condensed into the clear paste that relative density is 1.20 (50～55 ℃), adopts thin layer chromatography that wherein contained Herba Violae, Herba Taraxaci, Herba Lobeliae Chinensis are differentiated simultaneously; In inlet temperature is 150 ℃, and leaving air temp is under 60 ℃ the condition, above-mentioned clear paste to be carried out spray drying make dried cream powder; The Pulvis Talci and the magnesium stearate that in dried cream powder, add recipe quantity then, mixing is crossed 18 mesh sieves, and No. 0 capsule of packing into gets product, and adopts high performance liquid chromatography that the content of aesculetin in the finished product is detected simultaneously.
Embodiment 4:
Chinese violet containing capsule is characterized in that becoming 1000 by the preparation of raw material of following recipe quantity: Herba Violae 4000 grams, Herba Taraxaci 4000 grams, Radix Isatidis 4000 grams, Herba Lobeliae Chinensis 4000 grams, Pulvis Talci 96 grams, magnesium stearate 16.8 grams.
The preparation method of Chinese violet containing capsule comprises that raw material screening, weighing mix, decoct, filter, concentrate, dry, granulation and filling, inspection process, and concrete processing step is as follows:
Herba Violae, Herba Taraxaci, Radix Isatidis, Herba Lobeliae Chinensis four Chinese medicine material are removed impurity such as silt, behind the rejecting dis-medicinal part, be cut into long 1～1.5 centimetre section again; Take by weighing Herba Violae, Herba Taraxaci, Radix Isatidis and the Herba Lobeliae Chinensis of above-mentioned recipe quantity, add the water of 20 times of amounts behind the mixing, decoct 2 times, decocted 1 hour at every turn, the decocting liquid after will at every turn decocting simultaneously filters the back with 100 order nylon cloths and merges; The decocting liquid that adopts reduced vacuum to concentrate after mode will merge is condensed into the clear paste that relative density is 1.4 (50～55 ℃), adopts thin layer chromatography that wherein contained Herba Violae, Herba Taraxaci, Herba Lobeliae Chinensis are differentiated simultaneously; In inlet temperature is 100 ℃, and leaving air temp is under 45 ℃ the condition, above-mentioned clear paste to be carried out spray drying make dried cream powder; The Pulvis Talci and the magnesium stearate that in dried cream powder, add recipe quantity then, mixing is crossed 16 mesh sieves, and No. 0 capsule of packing into gets product, and adopts high performance liquid chromatography that the content of aesculetin in the finished product is detected simultaneously.
Claims (3)
1, Chinese violet containing capsule is characterized in that becoming 1000 by the preparation of raw material of following weight parts:
Herba Violae 100～2000 gram Herba Taraxacis 100～2000 grams
Radix Isatidis 100～2000 gram Herba Lobeliae Chinensis 100～2000 grams
Pulvis Talci 14 gram magnesium stearate 4.2 grams
2, the preparation method of Chinese violet containing capsule according to claim 1 is characterized in that comprising that raw material screening, weighing mix, decoct, filter, concentrate, dry, granulation and check, filling work procedure, and concrete processing step is as follows:
A, Herba Violae, Herba Taraxaci, Radix Isatidis, Herba Lobeliae Chinensis four Chinese medicine material are removed impurity such as silt, reject dis-medicinal part after, it is cut into long 1～1.5 centimetre section again;
B, take by weighing the above-mentioned four Chinese medicine of recipe quantity, add the water of 6～20 times of amounts behind the mixing, decoct 2～3 times, decocted 1～3 hour at every turn;
C, the decocting liquid after will at every turn decocting remerges after filtering with 100 order silks or nylon cloth respectively;
D, the decocting liquid that adopts reduced vacuum to concentrate after mode will merge are condensed into the clear paste that relative density is 1.0～1.40 (50～55 ℃), adopt thin layer chromatography that wherein contained Herba Violae, Herba Taraxaci, Herba Lobeliae Chinensis are differentiated simultaneously;
E, be 100～150 ℃ in inlet temperature, leaving air temp is under 45～50 ℃ the condition, above-mentioned clear paste is sprayed or vacuum drying makes dried cream powder;
F, add the Pulvis Talci and the magnesium stearate of recipe quantity in above-mentioned dried cream powder, mixing is crossed 10～60 mesh sieves, and No. 0 capsule of packing into gets product, and adopts high performance liquid chromatography that the content of aesculetin in the finished product is detected simultaneously.
3, the preparation method of Chinese violet containing capsule according to claim 2, the relative density that it is characterized in that described clear paste are 1.08 (50～55 ℃).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100813465A CN1310658C (en) | 2004-11-29 | 2004-11-29 | Chinese violet containing capsule and its preparing process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100813465A CN1310658C (en) | 2004-11-29 | 2004-11-29 | Chinese violet containing capsule and its preparing process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1634383A true CN1634383A (en) | 2005-07-06 |
| CN1310658C CN1310658C (en) | 2007-04-18 |
Family
ID=34847187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100813465A Expired - Fee Related CN1310658C (en) | 2004-11-29 | 2004-11-29 | Chinese violet containing capsule and its preparing process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1310658C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107029056A (en) * | 2017-02-28 | 2017-08-11 | 吉林修正药业新药开发有限公司 | It is a kind of to treat Chinese medicine composition of canker sore and preparation method thereof |
| CN109856262A (en) * | 2019-01-09 | 2019-06-07 | 广西中医药大学 | A kind of method that can be used for two fourth preparation main component quantification and qualifications simultaneously |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1456264A (en) * | 2003-02-21 | 2003-11-19 | 毛友昌 | Preparation of composite south isatis root capsules |
-
2004
- 2004-11-29 CN CNB2004100813465A patent/CN1310658C/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107029056A (en) * | 2017-02-28 | 2017-08-11 | 吉林修正药业新药开发有限公司 | It is a kind of to treat Chinese medicine composition of canker sore and preparation method thereof |
| CN109856262A (en) * | 2019-01-09 | 2019-06-07 | 广西中医药大学 | A kind of method that can be used for two fourth preparation main component quantification and qualifications simultaneously |
| CN109856262B (en) * | 2019-01-09 | 2021-07-30 | 广西中医药大学 | Method for qualitative and quantitative analysis of main components of Erding preparation simultaneously |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1310658C (en) | 2007-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111358839A (en) | Formula granules of polygonum capitatum and preparation method thereof | |
| CN1927293A (en) | Chinese medicine composition for treating skin burn and scald | |
| CN101152449A (en) | Method of preparing traditional Chinese medicine preparation for treating tummy bug | |
| CN1310658C (en) | Chinese violet containing capsule and its preparing process | |
| CN1887324A (en) | Chinese composition and its prepn process and quality control method | |
| CN1712060A (en) | Preparation of Chinese medicinal mixture for treating gynecologic menstrual disease | |
| CN1839934A (en) | Chinese traditional medicine and its preparation method and use | |
| CN1259078C (en) | Chinese medicine for treating women's chronic pelvic infection | |
| CN1309367C (en) | Preparation of Chinese traditional medicine for curing gallstone and preparation method | |
| CN101066425A (en) | Chinese medicine prepn for treating ungual mycosis | |
| CN101066355A (en) | Chinese medicine prepn for treating toothache and its prepn process | |
| CN1059117C (en) | Katsutoxin pill for tumor and preparing method thereof | |
| CN1548120A (en) | Pain-relieving and abdominal mass-eliminatnig bolus and its prepn | |
| CN1269815C (en) | Novel process for preparation of silybum mariamum extractive methylglucamine | |
| CN1861158A (en) | Dispersing tablets of Liuwei-dihuang extract or its add-substract components, and its prepn. method | |
| CN1745786A (en) | Zhimiling preparation and its making method thereof | |
| CN1586584A (en) | Sinusitis capsule and its preparing method | |
| CN1709478A (en) | Method for preparing Chinese medicine formulation for treating gynaecological disease | |
| CN1872160A (en) | Sloly released tablet of red sage root, and preparation method | |
| CN1733107A (en) | Medicine for treating coronary disease and apoplexy sequelae and process for preparing the same | |
| CN1954879A (en) | Granule of zhamusa-four-does and its preparation method | |
| WO2024077488A1 (en) | Relinqing granules having improved biological activity and disease treatment method | |
| CN1548114A (en) | Blood stasis eliminating and mass dissipating bolus and its prepn | |
| CN1528401A (en) | Pearl detoxifying oral liquid and preparing method tehreof | |
| CN1608661A (en) | Capsule preparation for treating gynecological diseases and preparation process thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: CHENGDU GOLDEN CICADA MEDICAL CO., LTD. Free format text: FORMER OWNER: CUI YI Effective date: 20131205 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 110014 SHENYANG, LIAONING PROVINCE TO: 611731 CHENGDU, SICHUAN PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20131205 Address after: 611731 No. 12 West core road, hi tech Zone, Sichuan, Chengdu Patentee after: Chengdu informed Pharmaceutical Co., Ltd. Address before: 110014, A 4-9-2, friendship garden, 107-1 South Avenue, the Yellow River District, Shenyang, Liaoning, Huanggu Patentee before: Cui Yi |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070418 Termination date: 20141129 |
|
| EXPY | Termination of patent right or utility model |